Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression

Transplant International

Volumn 17, Issue 7, 2004, Pages 366-369

  Roka, Sebastian ^a   Rasoul Rockenschaub, Susanne ^a   Roka, Julia ^a   Kirnbauer, Reinhard ^a   Mühlbacher, Ferdinand ^a   Salat, Andreas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anal neoplasia; Human papillomavirus; Organ transplantation

Indexed keywords

VIRUS DNA;

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; CONTROLLED STUDY; DNA DETERMINATION; DNA HYBRIDIZATION; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH CARE POLICY; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RATE; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RECTUM MUCOSA; RNA HYBRIDIZATION; SCREENING TEST; STATISTICAL SIGNIFICANCE; SURGICAL PATIENT; UNIVERSITY HOSPITAL; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS STRAIN; WART VIRUS;

ADULT; AGED; FEMALE; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RECTAL DISEASES; RISK FACTORS;

EID: 4544226050     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.tb00456.x     Document Type: Article

References (22)

1. Penn I. Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet 1986; 162:603.
2. Penn I, Occurrence of cancer in immune deficiencies. Cancer, 1974; 34, suppl:858.
3. Porreco R, Penn I, Droegemueller W, Greer B, Makowski E. Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol 1975; 45:359.
4. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681.
5. Fairley CK, Sheil AG, McNeil JJ, Ugoni AM, Disney AP, Giles GG, et al. The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol 1994; 41:101.
6. Müller H, Petritsch P, Wirnsberger G, Holzer H, Tscheliessnigg K. Renal Transplantation Eur Surg 2003; 35:315.
7. Melbye M, Rabkin C, Frisch M, Biggar RJ. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 1994; 139:772.
8. Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark. BMJ 1993; 306:419.
9. Beutner KR, Tyring S. Human papillomavirus and human disease. Am J Med 1997; 102:9.
10. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000; 283:87.
11. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102:3.
12. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994; 86:494.
13. Mathews WC. Screening for anal dysplasia associated with human papillomavirus. Top HIV Med 2003; 11:45.
14. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177:361.
15. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12:495.
16. Ogunbiyi OA, Scholefield JH, Raftery AT, Smith JH, Duffy S, Sharp F, et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994; 81:365.
17. Horl WH. Neutrophil function and infections in uremia. Am J Kidney Dis 1999; 33:xlv.
18. Bahr MJ, Manns MP. Funktion des Immunsystems bei Leberzirrhose. Z Gastroenterol 2001; 39:601.
19. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 2000; 108:634.
20. Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, et al. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 2003; 12:477.
21. Kirnbauer R, Taub J, Greenstone H, Roden R, Durst M, Gissmann L, et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 1993; 67:6929.
22. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347:1645.